HELIX ACQUISITION CORP. HLXA 深 沪
交易中 03-25 11:46:23 美东时间
13.25
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 13.25
- 总市值 1.96亿
- 52周最高 15.19
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 8.90
- 委 比 0.00%
- 总股本 1480.50万
- 历史最高 15.19
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.90
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioCardia Reports 2025 Business Highlights and Financial Results
BioCardia公司公布了截至2025年12月31日的全年财务结果，并提交了年度报告。公司表示正在推进CardiAMP®细胞疗法的临床试验和监管审批进程，包括在日本和美国的市场准入申请。此外，公司还宣布将在3月24日召开企业更新电话会议，讨论业务亮点。财务方面，2025年公司净亏损为822.8万美元，较2024年有所扩大，研发投入增加至496.2万美元，主要用于临床试验和监管活动。公司现金及等价物为249.6万美元。
03-24 20:05
Kevin O'Leary Slams 'Government-Subsidized' Intel Chips After Robot Malfunction: 'We Should Have Never Funded...'
Kevin O'Leary slams government-funded Intel chips after a robot malfunctions near fries, saying, "We should have never funded that company."
03-24 15:35
Altria expands distribution of its oral nicotine pouch line
Altria (MO) announced on Monday that on! PLUS is moving from limited regional and e‑commerce distribution to nationwide retail availability in the U.S., following its earlier launch in select states a...
03-24 03:54
Helix Biopharma GAAP EPS of -$0.05
Helix Biopharma press release (HBPCF): 1H GAAP EPS of -$0.05. The Company incurred a net and total comprehensive loss from operationsof $694,000 for the three months ended January 31, 2026, and a loss...
03-18 03:49
Helix BioPharma Corp. GAAP EPS of C$-0.01
Helix BioPharma Corp. press release (HBP:CA): Q2 GAAP EPS of C$-0.01. Reported a net and total comprehensive loss from operations of C$0.7M in Q2 2026. The Company had cash of C$0.03M as of January 31...
03-18 00:06
BRIEF-BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA
BRIEF-BioCardia Announces Pre-Submission Approval Package For Helix Transendocardial Delivery Catheter Accepted By FDA March 17 (Reuters) - BioCardia Inc BCDA.O : BIOCARDIA ANNOUNCES PRE-SUBMISSION APPROVAL PACKAGE FOR HELIX TRANSENDOCARDIAL DELIVERY CATHETER ACCEPTED BY FDA Source text: ID:nGNX1hL3
03-17 18:18
FDA accepts BioCardia Helix catheter pre-submission package
FDA accepts BioCardia Helix catheter pre-submission package BioCardia said the FDA accepted its pre-submission package seeking approval of the Helix transendocardial delivery catheter for intramyocardial delivery of therapeutic and diagnostic agents. The company said it has held preliminary meetings
03-17 18:01
BRIEF-Crawford Contractor Connection Announces Strategic Partnership With Helixco
BRIEF-Crawford Contractor Connection Announces Strategic Partnership With Helixco Crawford & Co CRDb.N : CRAWFORD CONTRACTOR CONNECTION ANNOUNCES STRATEGIC PARTNERSHIP WITH HELIXCO Source text: ID:nBw45xm71a Further company coverage: [CRDb.N]
03-16 22:29
Contractor Connection To Leverage Helixco's Platform To Offer Visibility Into Labor, Equipment, Cost Documentation
Contractor Connection®, a leading managed repair network and a Crawford & Company® business, is pleased to announce a strategic partnership with Helixco, a technology platform designed to capture and
03-16 22:05
Crawford’s Contractor Connection partners with Helixco on commercial managed repair program
Crawford’s Contractor Connection partners with Helixco on commercial managed repair program Contractor Connection, a managed repair network business of Crawford, announced a strategic partnership with Helixco. Helixco will provide a technology platform to capture and validate time-and-materials docu
03-16 22:00
